Omkar Speciality Chemicals

Resolution Plan Approved by NCLT on 31 July 2025
Total Resolution Amount: ₹26.65 crore
Funds Infused (up to Dec 2025): ₹15.08 crore

Reader Takeaway: Resolution plan approval positive; zero revenue and losses are key pressures.

What just happened

Omkar Speciality Chemicals' resolution plan was approved by the National Company Law Tribunal (NCLT) on July 31, 2025. The total resolution amount is ₹26.65 crore. As of December 2025, ₹15.08 crore has been infused. The company is operating on a going concern basis.

Why this matters

The NCLT approval marks a critical step in the company's revival. The infusion of funds is intended to stabilize operations, though the company reported zero revenue and continued net losses for the quarters ending June, September, and December 2025.

The backstory

Omkar Speciality Chemicals underwent a Corporate Insolvency Resolution Process (CIRP). The financial statements reflect losses accumulated prior to the resolution plan, resulting in a negative net worth. Comparative financial data for FY 2024-25 is unavailable due to CIRP.

What changes now

Management has transitioned following the NCLT approval. Mr. Dipak Kumar Shaw is the new CEO, and Mr. Ruhini Kumar Chakraborty joins as an Independent Director. The Audit Committee and Stakeholder's Relationship Committee have been reconstituted. M/s. R.R. Tibrewala & Co. and M/s. Aabid & Co. are the new statutory and secretarial auditors, respectively, for FY 2025-26.

Risks to watch

Significant risks include the company's continued lack of operational revenue and ongoing net losses. The auditors' report includes a note on material uncertainty regarding the going concern assumption, despite the resolution plan.

Peer comparison

Due to the CIRP and lack of recent operational data, a direct peer comparison for current financial performance is not feasible. The company's focus is on operational revival post-resolution.

Context metrics (time-bound)

• Net Loss Q1 2025-26: ₹0.41 crore
• Net Loss Q2 2025-26: ₹0.52 crore
• Net Loss Q3 2025-26: ₹0.33 crore
• Total Assets (as of 30 Sep 2025): ₹46.23 crore

What to track next

Investors should monitor the company's progress in generating revenue, improving its financial health, and stabilizing its operations under the new management and resolution plan.